Skip to main content
OpenTrials
Completed

NCT Number: NCT05642598

Pilot Study of a Smartphone-Based Vaping Cessation Program

Prospective, open label, single center clinical study enrolling up to 100 participants to evaluate the effect of the Pivot vaping cessation program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pivot Health Technologies, Inc.

San Carlos, California, 94070, United States

About this study

This is a prospective, open label, single center clinical study conducted with IRB approval enrolling up to 100 adult participants who report daily vaping. The study will be performed remotely on an ambulatory basis.

Participants will be asked to set up and use the "Pivot for Vape" program. The program includes an app, moderated online community, and SMS-based coaching with a tobacco treatment specialist. The study duration is 52 weeks, with the estimated active time using the program of up to 6 months and the time thereafter as follow-up. Participants will receive online questionnaires at intervals throughout the study.

Potential participants will complete an online screening form. Eligible participants will be called to confirm eligibility, discuss the study, and have their questions about the study answered. Interested eligible participants will complete the electronic informed consent form and baseline questionnaire prior to downloading the app on their smartphone.

The investigators aim to assess the performance of the "Pivot for Vape" program, with a focus on assessing use and engagement, changes in attitudes towards quitting vaping and changes in vaping behavior over the course of the 1-year study, as well as participant feedback on the set-up, design, use experience, and impact of the program.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current daily nicotine vape/e-cigarette user for at least the past 30 days
  • Plans to quit vaping in the next 6 months
  • Reports average VSPD ≥ 5
  • Interested in working with a vape cessation coach via SMS text
  • Resident of the United States
  • Able to read and comprehend English
  • Owns and uses a smartphone compatible with the study app (iPhone 5 and above with operating system iOS 12 and above, or, Android 7.0 and above with operating system Android 7.0 and above)
  • Has daily internet access on smartphone
  • Comfortable downloading and using smartphone apps
  • Willing to sign the Informed Consent Form (ICF)

Exclusion criteria

  • Using other vaping cessation apps, coaching, classes, or quit programs at entry
  • Currently using cigarettes
  • If previous cigarette smoker, need to have quit smoking at least 3 months ago (self-report)
  • Failure to provide contact or collateral information, and/or failure to verify email address
  • Participation in a previous study sponsored by Pivot Health Technologies Inc. (formerly Carrot Inc.)

Treatment and study plan

Pivot for Vape

Behavioral

"Pivot for Vape" vaping cessation smartphone app and program

Primary outcomes

  1. Vaping cessation rate: 30-day PPA

    Time frame: 6 months (26 weeks)

    30-day point prevalence abstinence (PPA) is defined as a participant self-report of no vaping for the past 30 days

Secondary outcomes

  1. Change in expected difficulty in staying quit

    Time frame: 6 months (26 weeks)

    Participant self report. Difficulty staying quit (DTQ), scale 1-10, higher values indicate greater difficulty staying quit (vape free).

  2. Change in confidence levels toward quitting vaping (expected success in quitting)

    Time frame: 6 months (26 weeks)

    Participant self report. Confidence levels or expected success in quitting (STQ), scale 1-10, higher values indicate greater confidence/greater expected success in quitting.

  3. Desire to quit vaping

    Time frame: 4 weeks

    Desire to quit vaping defined as a participant self-report of "yes" to "Would you like to completely stop vaping/using e-cigarettes?". Answer options include "yes" and "no".

  4. Vaping cessation rate: 7-day PPA

    Time frame: 6 months (26 weeks)

    7-day point-prevalence abstinence (PPA) is defined as a participant self-report of no vaping in the past 7 days.

  5. Self-reported continuous abstinence at 26 weeks

    Time frame: 6 months (26 weeks)

    Defined as a self-report of 7-day (or greater) ppa at 12 weeks, self-report of 30-day ppa at 26 weeks, and no. more than 5 vaping sessions since 12 weeks.

  6. Self-reported continuous abstinence at 52 weeks

    Time frame: 1 year (52 weeks)

    Defined as a self-reported continuous abstinence at 26 weeks and self-report of 30-day ppa at 52 weeks.

  7. Self-reported serial abstinence

    Time frame: 1 year (52 weeks)

    Defined as a self-report of continuous abstinence at 26 weeks, a self-report of 30-day ppa at 52 weeks, and no more than 5 vaping sessions since 26 weeks.

  8. Self-reported abstinence from all tobacco products

    Time frame: 6 months (26 weeks)

    Tobacco product use is self-reported. Participants are asked about the following products: cigars, cigarillos, little filtered cigars, a regular pipe, cigarettes, hookah or water pipe, smokeless tobacco, chew, and snuff

  9. The proportion of participants who reduced their vaping sessions per day (VSPD) by ≥ 50% compared to baseline

    Time frame: 6, 12, 26, and 52 weeks

    Number of vape session per day (VSPD) are self-reported

  10. Percent change in vape sessions per day (VSPD) compared to baseline

    Time frame: 6 months (26 weeks)

    Number of vape session per day (VSPD) are self-reported

  11. The proportion of participants who reduced the amount of vape juice / e-liquid consumed by ≥ 50% compared to baseline

    Time frame: 6, 12, 26, and 52 weeks

    Vape juice / e-liquid consumption volume is self-reported in mL/day or mL/week

  12. Percent change in the amount of vape juice / e-liquid consumed compared to baseline

    Time frame: 6 months (26 weeks)

    Vape juice / e-liquid consumption volume is self-reported in mL/day or mL/week

  13. The proportion of participants who reduced their vape juice / e-liquid nicotine concentration by ≥ 50% compared to baseline

    Time frame: 6, 12, 26, and 52 weeks

    Nicotine concentration is self-reported in mg/mL

  14. The proportion of participants who report decreased/unchanged/increased vaping compared to baseline

    Time frame: 6, 12, 26, and 52 weeks

    Amount of vaping is quantified as volume/day (mL/day) x concentration of nicotine (mg/mL)

  15. Number of quit attempts

    Time frame: 4, 12, 26, and 52 weeks

    Defined as participant answering ≥1 to the following question: "Since you began the study, how many times have you tried to quit vaping where you've gone at least 1 day without vaping, even a single puff?"

  16. Change in vaping / e-cig dependence

    Time frame: 12, 26, and 52 weeks

    Assessed via the Penn State Electronic Cigarette Dependence Index, 10 items. Possible scores on the index range from 0-20. Scores from 0-3 indicate no dependence, 4-8 low dependence, 9-12 medium dependence, 13+ high dependence

  17. User feedback - starting the vaping cessation program

    Time frame: 2 weeks

    Specifically regarding set-up and getting started with the program. Participants asked: "How easy or difficult was it to set-up and get started in the Pivot program?". Answered on a range from 1-10; 1 = Very difficult, and 10 = Very easy. A higher score indicates greater ease of program set-up and getting started.

  18. User satisfaction - Net Promoter Score

    Time frame: 4, 12, and 26 weeks

    Specifically regarding likelihood to recommend to a friend, Net Promoter Score (NPS). Participants asked: "How likely are you to recommend your study program to a friend or colleague?". Answered on a range from 1-10; 1 = Not at all likely, and 10 = Very likely. A higher score indicates greater user satisfaction and promotion of the program.

  19. User satisfaction - helpful for quitting

    Time frame: 8 and 12 weeks

    Specifically regarding whether the program was useful in helping participants quit vaping. Participants are asked: "Which of the following best describes the Pivot program's ability to help someone quit vaping?". Answer choices include the following: "The program is extremely helpful to quitting vaping"; "The program is helpful to quitting vaping"; "The program does not affect being able to quit vaping"; and "The program makes quitting vaping harder".

  20. Engagement with program - app openings

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with number of times the Pivot app was opened (number of app openings), number of days the app was opened, and the number of weeks the app was opened.

  21. Engagement with program - number of days with app openings

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with the number of days over which the app was opened by participants.

  22. Engagement with program - number of weeks with app openings

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with the number of weeks over which the app was opened by participants.

  23. Engagement with program - average duration of app sessions

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with the average duration of app sessions completed by participants. Outcome unit of measure = duration in minutes.

  24. Engagement with program - use of app features

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with the use of app features (practice quits, challenges, logging vape sessions) by participants. Reported as the number of times each app feature was used.

  25. Engagement with coach

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Engagement is specifically assessed with average number of messages sent by coach to participant per week and average number of messages sent by participant to coach per week.

  26. Average number of weeks with coach engagement

    Time frame: 6 months (26 weeks)

    Collected via back-end app data collection. Specifically, the average number of weeks with at least one message sent from participant to coach.

  27. Change in participant self-reported health

    Time frame: 6 months (26 weeks)

    Participant health is assessed with the following: "Would you say that in general your health is... Select one" And the following choices: "Excellent", "Very good", "Good", "Fair", and "Poor"

  28. Use of other vaping cessation tools

    Time frame: 6 months (26 weeks)

    Assessed via self-report. Participants are asked about other vaping cessation tools they have used throughout the last 6 months. Tools asked about include: apps (other than Pivot), counseling, medications, acupuncture, hypnotherapy, etc. Participants can report other tools not included in the list provided. Outcome reported as the number of participants who have used each other vaping cessation tool.

  29. Alcohol use behavior

    Time frame: 12, 26, and 52 weeks

    Assessed via the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) screening questionnaire, 3 items. A score is calculated from a sum of the 3 items. Possible scores on the scale range from 0-12. A score of 0 indicates no alcohol use. Higher scores indicate greater alcohol use behavior, a worse outcome.

  30. Presence of depressive symptoms

    Time frame: 12, 26, and 52 weeks

    Assessed via the Center of Epidemiological Studies Depression Scale (CES-D) screening questionnaire, 10 items. A score is calculated from a sum of the 10 items. Possible scores on the scale range from 0-30. Higher scores indicate greater severity of depressive symptoms, a worse outcome.

  31. Living environment relating to vaping and cigarette smoking

    Time frame: 12, 26, and 52 weeks

    Assessed via participant self-report of living with other adults who vape and/or smoke, living with a romantic partner who vapes and/or smokes. Participants asked: "Of the adults you live with, how many smoke cigarettes?" and "Of the adults you live with, how many vape/use e-cigs?". Outcome unit of measure = number of adults.

  32. Living/relationship environment relating to vaping and cigarette smoking

    Time frame: 12, 26, and 52 weeks

    Assessed via participant self-report of living with a romantic partner who vapes and/or smokes. Participants asked: "Do you live with a romantic partner who smokes cigarettes?" (yes/no) and "Do you live with a romantic partner who vapes/uses e-cigs?" (yes/no). Outcomes measure reported as number of participants who live with a romantic partner that smokes, and number that live with a romantic partner that vapes (participants that answer yes to these questions).

  33. Social environment relating to vaping and cigarette smoking

    Time frame: 12, 26, and 52 weeks

    Assessed via participant self-report of the number of their close friends who vape and/or smoke. Participants asked: "How many of your close friends smoke cigarettes?" and "How many of your close friends vape/use e-cigs?". Outcome unit of measure = number of close friends.

Sponsors and collaborators

Lead sponsor

Pivot Health Technologies Inc.

Industry

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 8, 2022
Registry last updated
Jan 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.